PPG Industries Inc
Change company Symbol lookup
Select an option...
PPG PPG Industries Inc
DUK Duke Energy Corp
CSCO Cisco Systems Inc
HMNF HMN Financial Inc
BAM Brookfield Asset Management Inc
XOM Exxon Mobil Corp
NEWR New Relic Inc
T AT&T Inc
AICAF Air China Ltd
MMM 3M Co
Go

Materials : Chemicals | Large Cap Value
Company profile

PPG Industries, Inc. manufactures and distributes a range of coatings and specialty materials. The Company has two segments: Performance Coatings and Industrial Coatings. The Performance Coatings segment includes the refinish, aerospace, protective and marine, architectural businesses. The Industrial Coatings segment includes the automotive original equipment manufacturer (OEM), industrial coatings, packaging coatings, coatings services and specialty coatings and materials businesses. The Company's geographical segments include the United States, Canada, Western Europe, Latin America, Central and Eastern Europe, the Middle East, Africa and Asia Pacific. The Company's brands include PPG, GLIDDEN, COMEX, OLYMPIC, DULUX, SIKKENS, PPG PITTSBURGH PAINTS, MULCO, FLOOD, LIQUID NAILS, SICO, CIL, RENNER, TAUBMANS, WHITE KNIGHT, BRISTOL, HOMAX, DEKORAL, TRILAK, GORI, and BONDEX, among others.

Postmarket

Last Trade
Delayed
$0.00
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$120.33
Day's Change
-1.41 (-1.16%)
Bid
--
Ask
--
B/A Size
--
Day's High
122.77
Day's Low
120.29
Volume
(Light)
Volume:
688,578

10-day average volume:
1,272,320
688,578

Lilly's stock rises as it announces late-stage trial for COVID-19 drug in nursing homes

7:32 am ET August 3, 2020 (MarketWatch)
Print

Shares of Eli Lilly & Co. (LLY) gained 1.1% in premarket trading on Monday after the drugmaker said it started a Phase 3 trial for a treatment that aims to prevent COVID-19 infections in residents and workers in nursing homes. It is estimated that at least 8% of U.S. COVID-19 cases and more than 41% of deaths have occurred in people linked to nursing homes, according to The New York Times (https://www.nytimes.com/interactive/2020/us/coronavirus-nursing-homes.html). Lilly is testing an experimental antibody it developed with the privately held AbCellera Biologics Inc. to see if it can prevent infections in people who live or work in a facility that has recently reported a case of the coronavirus. The antibody was identified in the blood sample of one of the first people in the U.S. to test positive for the virus. The trial, expected to enroll 2,400 people by September, will be conducted with the National Institute of Allergy and Infectious Diseases, with plans to release the late-stage data sometime in the fourth quarter. Lilly's stock has gained 14.3% so far this year. The S&P 500 is up 1.2%.

-Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

August 03, 2020 07:32 ET (11:32 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.